Pay in 4 interest-free payments of $27.45 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
PubMed Central PMCID: PMC4101245
is expressed during embryonal development and is absent in most normal
PubMed PMID: 31199090
Clarithromycin prevents bacteria by acting as a protein synthesis inhibitor
GO-6976 blocked neurotrophin-induced signaling and autophosphorylation of neurotrophin-specific tyrosine kinase (Trk) receptors
Radotinib Catalog No.:M10972-2 PubMed Central PMCID: PMC4101245Radotinib, also known as IY 5511, is an orally available, a second generation tyrosine kinase inhibitor of Bcr Abl fusion protein and the platelet derived growth factor receptor (PDGFR), with potential antineoplastic activity. Upon administration, radotinib specifically inhibits the Bcr Abl fusion protein, an abnormal enzyme expressed in Philadelphia chromosome positive chronic myeloid leukemia (CML) cells. In addition, this agent also inhibits PDGFR
US$ 85.00
US$ 70.00
US$ 126.00
US$ 175.00
US$ 70.00
US$ 157.50
US$ 70.00
US$ 123.75